These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 31247182)

  • 21. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality.
    deFilippi CR; Seliger SL; Maynard S; Christenson RH
    Clin Chem; 2007 Aug; 53(8):1511-9. PubMed ID: 17586595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early glomerular filtration rates changes and risk of mortality in acute heart failure. The modifying role of admission renal function and decongestion.
    Lorenzo M; Núñez G; Fuertes-Kenneally L; de la Espriella R; Villar S; Miró O; Llorens P; Santas E; Miñana G; Bodí V; Sanchis J; Carratalá A; Bayés-Genís A; Núñez J
    Eur J Intern Med; 2023 Sep; 115():96-103. PubMed ID: 37316355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
    Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ
    Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial differences in the association of NT-proBNP with risk of incident heart failure in REGARDS.
    Patel N; Cushman M; Gutiérrez OM; Howard G; Safford MM; Muntner P; Durant RW; Prabhu SD; Arora G; Levitan EB; Arora P
    JCI Insight; 2019 Jun; 5(13):. PubMed ID: 31162140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of Cysteine-Rich Protein 61 Combined with N-Terminal Pro-B-Type Natriuretic Peptide for Mortality in Acute Heart Failure Patients with and without Chronic Kidney Disease.
    Liu C; Liang W; He X; Owusu-Agyeman M; Wu Z; Zhou Y; Cao Y; Zhang C; Liu J; Jiang J; Dong B; Xue R; Wu D; Dong Y; Zhao J
    Cardiorenal Med; 2020; 10(1):11-21. PubMed ID: 31473733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
    Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of decompensated heart failure: role of NT-proBNP.
    Ferreira S; Almeida R; Guerrero H; Lourenço-Ferreira S; Fonseca L; Rocha R; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Rev Port Cardiol; 2007 May; 26(5):535-45. PubMed ID: 17691279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure.
    Schou M; Gustafsson F; Corell P; Kistorp CN; Kjaer A; Hildebrandt PR
    Am Heart J; 2007 Jul; 154(1):123-9. PubMed ID: 17584564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT.
    Ascher SB; Berry JD; Katz R; de Lemos JA; Bansal N; Garimella PS; Hallan SI; Wettersten N; Jotwani VK; Killeen AA; Ix JH; Shlipak MG
    Am J Kidney Dis; 2024 May; 83(5):615-623.e1. PubMed ID: 37992982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
    Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF.
    Voordes G; Davison B; Biegus J; Edwards C; Damman K; Ter Maaten J; Mebazaa A; Takagi K; Adamo M; Ambrosy AP; Arrigo M; Barros M; Celutkiene J; Čerlinskaitė-Bajorė K; Chioncel O; Cohen-Solal A; Damasceno A; Deniau B; Diaz R; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Metra M; Novosadova M; Pagnesi M; Pang P; Ponikowski P; Saidu H; Sliwa K; Tomasoni D; Cotter G; Voors AA
    Eur J Heart Fail; 2024 Jul; 26(7):1480-1492. PubMed ID: 38874185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study.
    Mohammed AA; van Kimmenade RR; Richards M; Bayes-Genis A; Pinto Y; Moore SA; Januzzi JL
    Circ Heart Fail; 2010 May; 3(3):354-61. PubMed ID: 20332419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amino-terminal pro-brain natriuretic Peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction?
    van Kimmenade RR; Januzzi JL; Baggish AL; Lainchbury JG; Bayes-Genis A; Richards AM; Pinto YM
    J Am Coll Cardiol; 2006 Oct; 48(8):1621-7. PubMed ID: 17045898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction.
    Savarese G; Hage C; Orsini N; Dahlström U; Perrone-Filardi P; Rosano GM; Lund LH
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 28029640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-terminal pro-B-type natriuretic peptide-guided therapy in patients hospitalized for acute heart failure.
    Carubelli V; Lombardi C; Lazzarini V; Bonadei I; Castrini AI; Gorga E; Richards AM; Metra M
    J Cardiovasc Med (Hagerstown); 2016 Nov; 17(11):828-39. PubMed ID: 27322401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure.
    Aimo A; Januzzi JL; Vergaro G; Ripoli A; Latini R; Masson S; Magnoli M; Anand IS; Cohn JN; Tavazzi L; Tognoni G; Gravning J; Ueland T; Nymo SH; Rocca HB; Bayes-Genis A; Lupón J; de Boer RA; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Tentzeris I; Wilson Tang WH; Grodin JL; Passino C; Emdin M
    Int J Cardiol; 2019 Feb; 277():166-172. PubMed ID: 30416028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure.
    de la Espriella R; Bayés-Genís A; Llàcer P; Palau P; Miñana G; Santas E; Pellicer M; González M; Górriz JL; Bodi V; Sanchis J; Núñez J
    Eur J Intern Med; 2022 Jan; 95():67-73. PubMed ID: 34507853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients.
    Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
    JACC Heart Fail; 2016 Sep; 4(9):736-45. PubMed ID: 27395353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure.
    Chuang CP; Jong YS; Wu CY; Lo HM
    Am J Cardiol; 2014 Mar; 113(5):845-50. PubMed ID: 24406111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.